NRAS and melanoma: Currently, genetic studies suggest that melanoma is one of the highest mutated malignancies (Alexandrov et al., 2013), of which two prominent mutational events, BARF and NRAS, are observed in approximately 40–60% (Flaherty et al., 2010) and 15–20% (Mandala et al., 2014) of all melanoma cases, respectively.